Evidence map›Paper›PMID 25557463›Full record

ArticleNeuromuscular disorders : NMD2015

Autophagic vacuolar pathology in desminopathies.

Conrad C Weihl, Stanley Iyadurai, Robert H Baloh, Sara K Pittman, Robert E Schmidt, Glenn Lopate, Alan Pestronk, Matthew B Harms

Open access · greenAbstract read
In one paragraph

Article in Neuromuscular disorders : NMD, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Differential diagnosis of vacuolar myopathies in the NGS era.Brain pathology (Zurich, Switzerland) · 2020
    Article
  6. Article
  7. Desmin forms toxic, seeding-competent amyloid aggregates that persist in muscle fibers.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Conrad C WeihlDepartment of Neurology and Hope Center for Neurologic Disorders, Washington University School of Medicine, Saint Louis, MO, USA. Electronic address: weihlc@neuro.wustl.edu.
Stanley IyaduraiDepartment of Neurology, The Ohio State University College of Medicine, Columbus, OH, USA.
Robert H BalohDepartment of Neurology, Regenerative Medicine Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Sara K PittmanDepartment of Neurology and Hope Center for Neurologic Disorders, Washington University School of Medicine, Saint Louis, MO, USA.
Robert E SchmidtDepartment of Pathology, Washington University School of Medicine, Saint Louis, MO, USA.
Glenn LopateDepartment of Neurology and Hope Center for Neurologic Disorders, Washington University School of Medicine, Saint Louis, MO, USA.
Alan PestronkDepartment of Neurology and Hope Center for Neurologic Disorders, Washington University School of Medicine, Saint Louis, MO, USA.
Matthew B HarmsDepartment of Neurology and Hope Center for Neurologic Disorders, Washington University School of Medicine, Saint Louis, MO, USA.
Hope Center for Neurological Disorders · USCedars-Sinai Medical Center · USThe Ohio State University · USWashington University in St. Louis · US

Funding

VCP in myopathy and dementiaR01AG031867 · NIA · WASHINGTON UNIVERSITY · PI CONRAD C WEIHL · 2009 to 2026
$9.1M
DEFINING THE MECHANISM OF TDP-43 RELATED NEURODEGENERATIONR01NS069669 · NINDS · WASHINGTON UNIVERSITY · PI BALOH, ROBERT · 2010 to 2014
$1.7M
Mechanism of Peripheral Neuropathy from Mitofusin 2 MutationsK08NS055980 · NINDS · WASHINGTON UNIVERSITY · PI BALOH, ROBERT · 2007 to 2011
$793k
NEXT-GENERATION SEQUENCING APPROACHES FOR NOVEL GENE DISCOVERY IN ALSK08NS075094 · NINDS · WASHINGTON UNIVERSITY · PI HARMS, MATTHEW · 2011 to 2015
$787k
AUTOPHAGIC DYSFUNCTION IN IBMPFD ASSOCIATED MUSCLE DISEASEK02AG042095 · NIA · WASHINGTON UNIVERSITY · PI WEIHL, CONRAD C · 2012 to 2016
$671k
NIA NIH HHS AG031867NIA NIH HHS AG042095NIA NIH HHS K02 AG042095NIA NIH HHS R01 AG031867NINDS NIH HHS K08 NS055980NINDS NIH HHS K08 NS075094NINDS NIH HHS NS055980NINDS NIH HHS NS069669NINDS NIH HHS NS075094NINDS NIH HHS R01 NS069669
6 · The paper itself

Abstract

Autophagic vacuolar myopathies are an emerging group of muscle diseases with common pathologic features. These include autophagic vacuoles containing both lysosomal and autophagosomal proteins sometimes lined with sarcolemmal proteins such as dystrophin. These features have been most clearly described in patients with Danon's disease due to LAMP2 deficiency and X-linked myopathy with excessive autophagy (XMEA) due to mutations in VMA21. Disruptions of these proteins lead to lysosomal dysfunction and subsequent autophagic vacuolar pathology. We performed whole exome sequencing on two families with autosomal dominantly inherited myopathies with autophagic vacuolar pathology and surprisingly identified a p.R454W tail domain mutation and a novel p.S6W head domain mutation in desmin, DES. In addition, re-evaluation of muscle tissue from another family with a novel p.I402N missense DES mutation also identified autophagic vacuoles. We suggest that autophagic vacuoles may be an underappreciated pathology present in desminopathy patient muscle. Moreover, autophagic vacuolar pathology can be due to genetic etiologies unrelated to primary defects in the lysosomes or autophagic machinery. Specifically, cytoskeletal derangement and the accumulation of aggregated proteins such as desmin may activate the autophagic system leading to the pathologic features of an autophagic vacuolar myopathy.

Indexed as

AdultAgedCardiomyopathiesDesminFamilyFemaleHandHumansImmunohistochemistryLysosomal Storage DiseasesMaleMicroscopy, ElectronMiddle AgedMuscle, SkeletalMuscular DiseasesMuscular DystrophiesDesminAutophagyDesminMyofibrillar myopathyProtein aggregation

Identifiers

PMID25557463
PMCPMC4355324
OpenAlexW2025582749

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.